Biologics Market - Positive Long-Term Growth Outlook 2027

Global Biologics Market – Overview

Biologics are compounds of pharmaceutical importance such as sugars, proteins, and nucleic acids or complex combinations of these substances, or they can be living entities by themselves which are inclusive of such cells and tissues. Biologics can be isolated from natural sources including human beings, animal, or microorganism, and may be produced by biotechnological procedures through various cutting-edge technologies.

The Global Biologics Market is growing with a sound pace. According to a recent study report published by the Market Research Future, the Global Biologics Market is booming and expected to gain prominence over the forecast period. The market is projected to demonstrate a sound growth by 2027, surpassing its previous growth records in terms of value with a striking CAGR during the anticipated period (2017 – 2027).

Global Biologics Market - Key Players

AbbVie, Amgen, Biogen Idec, Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline plc., Johnson and Johnson, Merck and Co., Merck KGaA, Novartis, Pfizer, F. Hoffmann-La Roche Ltd, and Sanofi are some of the prominent players at the forefront of competition in the Global Biologics Market and are profiled in MRFR Analysis.

Browse Complete 80 Pages Premium Research Report Enabled with 30+ Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/biologics-market-1339

Global Biologics Market - Segments

Global Biologics market has been segmented on the basis of product type which comprises of vaccines, blood and blood products, allergenic extracts, human cells and tissues, proteins, gene therapies, cellular therapies, xenotransplantation products and others. On the basis of applications, which consist of Rheumatoid arthritis, renal failure, Anemia, Cancer, Diabetes and others. On the basis of Source, which consist of Humans, Avian Cell Culture, Yeast, Bacteria, Insects Cell Culture, Transgenics and others.

Global Biologics Market - Competitive Analysis

Well established players incorporate acquisition, collaboration, partnership, expansion, and product launch in order to gain competitive advantage in this market and to maintain their market position.

Merck KGaA is one of the prominent players in the Global Biologics Market and is headquartered in Darmstadt, Germany. In January 2017, the company acquired acquired BioControl Systems Inc., a global leader in food safety testing. The acquisition opened growth opportunities for Merck in the food and beverage space; particularly in the U.S.

In August 2016, FDA approved Pfizer's TROXYCA ER extended-release capsules CII for pain management. This drug is used for abuse-deterrent properties for the management of pain and will help Pfizer to improve their goodwill and sales with this new product

In April 2017, F. Hoffmann-La Roche Ltd. received 510(k) clearance from the U.S. FDA for the CINtec Histology test. This test is the only clinically validated p16 biomarker test. The CINtec Histology test will help physicians make informed decisions as to the best course of care for patients with high-grade pre-cancerous cervical disease.

Market Drivers and Restraints:

The global market for biologics is majorly driven by the availability of wide range of biologics such as vaccines, allergenics, blood, blood components, somatic cells, tissues, gene therapies, living cells used in cell therapy and recombinant therapeutic protein. The increasing number of individuals with chronic and acute diseases, such as cancer, diabetes, anemia and others, that involves biologics in their treatment is inducing demand for biologics or biologic drugs in the global market.

The growing approval of patient-centric and personalized medicines and increasing resistance towards conventional drugs are impacting positively on the expansion of the global biologics market. The increasing inclination towards the adoption of medicines that are derived from natural sources owing to the high rate of side-effects caused by the conventional chemically synthesized drugs is creating traction for biologics in the global market, resulting in the expansion of the global biologics market.

The high success rate in terms of approval of biologic drugs has created a broad pathway of opportunities for the manufacturers, which in turn is fueling the growth of the global biologics market. The increased research and development expenditure by the pharmaceutical companies has led to the introduction of new and efficient biologic drugs in the global market, leading to the expansion of the global biologics market. However, the high capital investment for research and development of biologics, high cost of biologics and development of biosimilars are likely to act as a restraint on the growth of the global biologics market.

Global Biologics Market - Regional Analysis

Geographically, the North America has the largest biologic drug market. Due to increasing prevalence of diseases like Cancer and diabetes in the North America is the major factor for the growth of the market. North America is followed by Europe in biologic market. Asia Pacific is the fastest growing region for biologic market. Biologic market growth of Asia Pacific is majorly driven by Japan, China and India. Beside this a huge population base in this region has provided a fuel for the growth of the market. Middle East and Africa has the least biologic market.

For More Information Visit @ http://heraldkeeper.com/market/biologics-market-2018-blatant-growth-cagr-8-6-analysis-forecast-2027-174039.html

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: salesteam@marketresearchfuture.com

Market Research Future with their unique quality of simplifying the market research study, announces a qualitative study report on Huntington’s Disease Treatment Market